Belite Bio is a clinical stage biopharmaceutical drug development company.
Belite Bio has raised $350.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2025.
Belite Bio's investors include RA Capital Management, RTW Investments, Soleus Capital, Marshall Wace, Eventide.
Belite Bio is headquartered in San Diego, United States.
Belite Bio is a clinical stage biopharmaceutical drug development company.
Belite Bio is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Belite Bio — Funding & Investors." VCBacked, December 1, 2025, https://www.vcbacked.co/company/belite-bio. Accessed July 19, 2026.
VCBacked. (2025). Belite Bio — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/belite-bio
{{cite web |title=Belite Bio — Funding & Investors |url=https://www.vcbacked.co/company/belite-bio |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated